by Lab Admin | Aug 26, 2026 | Blog, More Info
The federal landscape for manufactured kratom products has shifted dramatically. On August 25, 2026, the U.S. Drug Enforcement Administration (DEA) issued a temporary emergency scheduling order placing three highly potent, synthetic kratom-related compounds into...
by Lab Admin | Aug 10, 2026 | Blog, More Info
Subject: Important Regulatory Update: Testing Availability for MGM-15, MGM-16, and Mitragynine Pseudoindoxyl — 1. The Federal Regulatory Status (Clarification) July 6, 2026 (Notice of Intent): The U.S. Drug Enforcement Administration (DEA) published a formal...
by Lab Admin | Aug 5, 2026 | Blog, More Info
How to Track Real-Time Kratom Regulatory Updates: Federal Register & Florida Compliance Portals In an era of rapid emergency rulemaking, staying ahead of regulatory changes is an operational necessity for quality assurance managers, analytical laboratories,...
by Lab Admin | Aug 5, 2026 | Blog, More Info
Florida’s Emergency Kratom Regulations: Rules 2ER26-1, 5KER26-9, and the Analytical CRM Bottleneck Florida has established itself as one of the most aggressive state regulatory environments for botanical supplements and novel alkaloid products. Through joint action...
by Lab Admin | Aug 5, 2026 | Blog, More Info
The Federal 7-OH Temporary Scheduling Order: DEA Docket DEA-1570, Concentration Thresholds, and Laboratory Compliance The regulatory landscape for Mitragyna speciosa and its derived alkaloids has reached a historical turning point. Following months of heightened...
